DENTSPLY SIRONA (NASDAQ:XRAY) Downgraded by Credit Suisse Group to Hold

Credit Suisse Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) to a hold rating in a research report report published on Friday, January 5th. The brokerage currently has $73.00 price target on the medical instruments supplier’s stock.

Several other equities research analysts also recently weighed in on the company. HC Wainwright downgraded DENTSPLY SIRONA from a buy rating to a neutral rating and set a $68.00 target price for the company. in a research report on Thursday, November 30th. Zacks Investment Research downgraded DENTSPLY SIRONA from a hold rating to a sell rating in a research report on Monday, October 30th. JPMorgan Chase & Co. upgraded DENTSPLY SIRONA from a neutral rating to an overweight rating and set a $75.00 price target on the stock in a research note on Wednesday, December 13th. Deutsche Bank initiated coverage on DENTSPLY SIRONA in a research note on Friday, December 8th. They issued a buy rating and a $81.00 price target on the stock. Finally, Morgan Stanley reiterated an overweight rating and issued a $69.00 price target (up previously from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and eight have assigned a buy rating to the stock. DENTSPLY SIRONA presently has a consensus rating of Hold and a consensus target price of $69.15.

Shares of DENTSPLY SIRONA (XRAY) traded down $0.59 during midday trading on Friday, hitting $60.81. The stock had a trading volume of 1,908,349 shares, compared to its average volume of 2,748,545. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $68.98. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.32 and a quick ratio of 1.59. The stock has a market capitalization of $14,235.75, a P/E ratio of -17.52, a price-to-earnings-growth ratio of 2.28 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $978.99 million. During the same quarter in the prior year, the business earned $0.66 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year. sell-side analysts expect that DENTSPLY SIRONA will post 2.65 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 12th. Investors of record on Friday, December 29th were paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.58%. The ex-dividend date was Thursday, December 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the sale, the director now owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Mark Thierer acquired 77,000 shares of the business’s stock in a transaction on Monday, November 13th. The shares were purchased at an average price of $66.04 per share, for a total transaction of $5,085,080.00. The disclosure for this purchase can be found here. Insiders own 1.99% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. BRYN MAWR TRUST Co raised its stake in DENTSPLY SIRONA by 0.5% during the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after buying an additional 65 shares in the last quarter. Nordea Investment Management AB raised its stake in DENTSPLY SIRONA by 0.7% during the second quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock valued at $664,000 after buying an additional 75 shares in the last quarter. Security National Bank of Sioux City Iowa IA raised its stake in DENTSPLY SIRONA by 0.4% during the second quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock valued at $1,497,000 after buying an additional 102 shares in the last quarter. Security National Bank of SO Dak raised its stake in DENTSPLY SIRONA by 1.1% during the second quarter. Security National Bank of SO Dak now owns 18,805 shares of the medical instruments supplier’s stock valued at $1,219,000 after buying an additional 207 shares in the last quarter. Finally, Commonwealth Bank of Australia raised its stake in DENTSPLY SIRONA by 19.0% during the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 260 shares in the last quarter. Hedge funds and other institutional investors own 96.52% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another domain, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/31/dentsply-sirona-xray-stock-rating-lowered-by-credit-suisse-group.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply